Happy Thanksgiving! Save 50% on Your MarketBeat All Access Subscription.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
S&P 500   4,026.12
DOW   34,347.03
QQQ   286.92
Considerations When Rolling Over a 401(k) into a Roth IRA
THE BEST BLACK FRIDAY DEAL YET (Ad)
Airbnb has a plan to fix cleaning fees
Saudi viewers angry over apparent ban on World Cup streaming
THE BEST BLACK FRIDAY DEAL YET (Ad)
Walmart shooting claims teen, young woman, father, mother
Cuba's informal market finds new space on growing internet
See how to make money instead of spending it on Black Friday with this offer (Ad)
Bird flu prompts slaughter of 1.8M chickens in Nebraska
US-England World Cup game seen by 19.98M on US television
NASDAQ:NVCN

Neovasc - NVCN Stock Forecast, Price & News

$8.01
+0.51 (+6.80%)
(As of 11/25/2022 08:58 PM ET)
Add
Compare
Today's Range
$7.49
$8.22
50-Day Range
$6.50
$8.01
52-Week Range
$4.59
$20.00
Volume
7,900 shs
Average Volume
12,903 shs
Market Capitalization
$21.97 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$125.00

Neovasc MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,460.5% Upside
$125.00 Price Target
Short Interest
Healthy
0.88% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.93mentions of Neovasc in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($11.95) to ($8.42) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.02 out of 5 stars

Medical Sector

678th out of 1,044 stocks

Surgical & Medical Instruments Industry

74th out of 104 stocks

NVCN stock logo

About Neovasc (NASDAQ:NVCN) Stock

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Receive NVCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

NVCN Stock News Headlines

StockNews.com Initiates Coverage on Neovasc (NASDAQ:NVCN)
Neovasc Third Quarter 2022 Earnings: Misses Expectations
Form 6-K NEOVASC INC For: Sep 20 - StreetInsider.com
Neovasc Announces Key Events at TCT 2022 - GlobeNewswire
Neovasc Announces Key Events at TCT 2022
Neovasc: Q2 Earnings Snapshot - Greenwich Time
See More Headlines
Receive NVCN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Neovasc and its competitors with MarketBeat's FREE daily newsletter.

NVCN Company Calendar

Last Earnings
11/09/2021
Today
11/27/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
3/09/2023

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:NVCN
Employees
49
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$125.00
High Stock Price Forecast
$125.00
Low Stock Price Forecast
$125.00
Forecasted Upside/Downside
+1,460.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
2 Analysts

Profitability

Net Income
$-24,890,000.00
Net Margins
-1,077.37%
Pretax Margin
-1,211.86%

Debt

Sales & Book Value

Annual Sales
$2.55 million
Book Value
$10.23 per share

Miscellaneous

Free Float
N/A
Market Cap
$21.97 million
Optionable
Not Optionable
Beta
1.96

Key Executives

  • Mr. Fredericus A. Colen (Age 70)
    Pres, CEO & Director
    Comp: $2.59M
  • Mr. Christopher Clark B.A. (Age 50)
    BA (Honours), C.A., CA, PgD, CFO & Corp. Sec.
    Comp: $1.07M
  • Mr. William Reed Little (Age 51)
    Chief Operating Officer
    Comp: $1.2M
  • Mr. John Christopher Panton (Age 55)
    Chief Quality Officer
    Comp: $380.98k
  • Sarah Marie-Hodgson Gallagher
    VP of Clinical Affairs













NVCN Stock - Frequently Asked Questions

Should I buy or sell Neovasc stock right now?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" NVCN shares.
View NVCN analyst ratings
or view top-rated stocks.

What is Neovasc's stock price forecast for 2023?

2 brokers have issued twelve-month price objectives for Neovasc's shares. Their NVCN share price forecasts range from $125.00 to $125.00. On average, they anticipate the company's stock price to reach $125.00 in the next twelve months. This suggests a possible upside of 1,460.5% from the stock's current price.
View analysts price targets for NVCN
or view top-rated stocks among Wall Street analysts.

How have NVCN shares performed in 2022?

Neovasc's stock was trading at $11.7150 at the start of the year. Since then, NVCN shares have decreased by 31.6% and is now trading at $8.01.
View the best growth stocks for 2022 here
.

When is Neovasc's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, March 9th 2023.
View our NVCN earnings forecast
.

How were Neovasc's earnings last quarter?

Neovasc Inc. (NASDAQ:NVCN) posted its earnings results on Tuesday, November, 9th. The medical equipment provider reported ($2.75) EPS for the quarter, missing analysts' consensus estimates of ($2.25) by $0.50. The medical equipment provider earned $0.70 million during the quarter, compared to the consensus estimate of $1.20 million. Neovasc had a negative trailing twelve-month return on equity of 76.22% and a negative net margin of 1,077.37%. During the same quarter in the previous year, the business posted ($12.75) EPS.

When did Neovasc's stock split?

Neovasc's stock reverse split on Friday, April 29th 2022. The 1-25 reverse split was announced on Friday, April 29th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Friday, April 29th 2022. An investor that had 100 shares of stock prior to the reverse split would have 4 shares after the split.

What other stocks do shareholders of Neovasc own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Neovasc investors own include Biopharmx (BPMX), Allstate (ALL), Amicus Therapeutics (FOLD), Synergy Pharmaceuticals (SGYP), Rexahn Pharmaceuticals (REXN), Heat Biologics (HTBX), Protalix BioTherapeutics (PLX), Palatin Technologies (PTN), Amarin (AMRN).

What is Neovasc's stock symbol?

Neovasc trades on the NASDAQ under the ticker symbol "NVCN."

How do I buy shares of Neovasc?

Shares of NVCN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Neovasc's stock price today?

One share of NVCN stock can currently be purchased for approximately $8.01.

How much money does Neovasc make?

Neovasc (NASDAQ:NVCN) has a market capitalization of $21.95 million and generates $2.55 million in revenue each year. The medical equipment provider earns $-24,890,000.00 in net income (profit) each year or ($12.29) on an earnings per share basis.

How can I contact Neovasc?

Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, RICHMOND A1, V6V 2J7. The official website for the company is www.neovasc.com. The medical equipment provider can be reached via phone at (604) 270-4344, via email at investors@neovasc.com, or via fax at 604-270-4384.

This page (NASDAQ:NVCN) was last updated on 11/28/2022 by MarketBeat.com Staff